GLI
GILD icon

Guardian Life Insurance’s Gilead Sciences GILD Stock Holding History

Guardian Life Insurance’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-3,726
Closed -$242K – 188
2019
Q4 		$242K Buy
3,726
+21
+0.6% +$1.37K 0.06% 80
2019
Q3 		$235K Buy
3,705
+16
+0.4% +$1.05K 0.04% 91
2019
Q2 		$249K Buy
3,689
+17
+0.5% +$1.12K 0.03% 88
2019
Q1 		$239K Hold
3,672
– – 0.03% 88
2018
Q4 		$230K Buy
3,672
+15
+0.4% +$1.05K 0.04% 83
2018
Q3 		$282K Buy
3,657
+61
+2% +$4.61K 0.05% 76
2018
Q2 		$255K Buy
3,596
+590
+20% +$41.7K 0.04% 74
2018
Q1 		$227K Sell
3,006
-1,223
-29% -$97.2K 0.04% 68
2017
Q4 		$303K Buy
4,229
+1,266
+43% +$96.1K 0.07% 71
2017
Q3 		$240K Buy
2,963
+7
+0.2% +$535 0.04% 64
2017
Q2 		$209K Sell
2,956
-2,093
-41% -$139K 0.03% 59
2017
Q1 		$343K Buy
5,049
+1
+0% +$70 0.05% 66
2016
Q4 		$361K Buy
5,048
+67
+1% +$4.98K 0.05% 74
2016
Q3 		$394K Sell
4,981
-144
-3% -$11.7K 0.04% 100
2016
Q2 		$428K Sell
5,125
-206
-4% -$18.3K 0.03% 120
2016
Q1 		$490K Sell
5,331
-1,509
-22% -$136K 0.04% 109
2015
Q4 		$692K Sell
6,840
-1,741
-20% -$181K 0.07% 96
2015
Q3 		$843K Buy
8,581
+2,141
+33% +$238K 0.09% 93
2015
Q2 		$754K Sell
6,440
-75
-1% -$8.2K 0.07% 91
2015
Q1 		$639K Sell
6,515
-2,084
-24% -$212K 0.06% 103
2014
Q4 		$811K Hold
8,599
– – 0.08% 102
2014
Q3 		$915K Sell
8,599
-127
-1% -$12.4K 0.09% 91
2014
Q2 		$723K Buy
8,726
+89
+1% +$6.93K 0.07% 101
2014
Q1 		$612K Hold
8,637
– – 0.05% 113
2013
Q4 		$649K Sell
8,637
-9,764
-53% -$680K 0.06% 114
2013
Q3 		$1.16M Buy
18,401
+80
+0.4% +$4.78K 0.1% 112
2013
Q2 		$938K Buy
+18,321
New +$955K 0.09% 116

Other funds holding GILD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Guardian Life Insurance's GILD Position: Q1 2020 in Review

Guardian Life Insurance sold out of Gilead Sciences (GILD) in Q1 2020, closing a stake of 3,726 shares — an estimated $242K sold.

Guardian Life Insurance first reported a position in GILD in Q2 2013 and held it in 27 quarters. The position peaked at $1.16M in Q3 2013. 1,643 funds tracked by Wall St. Rank hold GILD as of Q1 2020.

  • Guardian Life Insurance reported no remaining Gilead Sciences position as of Q1 2020 after selling out during the quarter.
  • Guardian Life Insurance sold 3,726 Gilead Sciences shares in Q1 2020, an estimated $242K.
  • Guardian Life Insurance first reported a position in Gilead Sciences in Q2 2013 and held it in 27 quarters.
  • Guardian Life Insurance's Gilead Sciences position peaked at $1.16M in Q3 2013.
  • 1,643 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2020.

Based on Guardian Life Insurance's 13F filing for Q1 2020.